82 FR 29908 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 125 (June 30, 2017)

Page Range		29908-29908
FR Document		2017-13697

Federal Register, Volume 82 Issue 125 (Friday, June 30, 2017)

[Federal Register Volume 82, Number 125 (Friday, June 30, 2017)]
[Notices]
[Page 29908]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-13697]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Regulatory Affairs Support (8933).
    Date: July 27, 2017.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, 
Bethesda, MD 20814.
    Contact Person: Lyle Furr, Scientific Review Officer, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 827-5702 lf33c.nih.gov.

(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: June 26, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-13697 Filed 6-29-17; 8:45 am]
 BILLING CODE 4140-01-P

29908 Federal Register / Vol. 82, No. 125 / Friday, June 30, 2017 / Notices

Name of Committee: Center for Scientific Name of Committee: National Institute on Dated: June 26, 2017.
Review Special Emphasis Panel; Vascular Drug Abuse Special Emphasis Panel; Sylvia L. Neal,
Biology and Hematology. Regulatory Affairs Support (8933). Program Analyst, Office of Federal Advisory
Date: July 27, 2017. Date: July 27, 2017. Committee Policy.
Time: 1:15 p.m. to 3:30 p.m. Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant Agenda: To review and evaluate contract [FR Doc. 2017–13694 Filed 6–29–17; 8:45 am]
applications. proposals. BILLING CODE 4140–01–P
Place: National Institutes of Health, 6701 Place: Hilton Garden Inn Bethesda, 7301
Rockledge Drive, Bethesda, MD 20892, Waverly Street, Bethesda, MD 20814.
(Telephone Conference Call). Contact Person: Lyle Furr, Scientific DEPARTMENT OF HEALTH AND
Contact Person: Larry Pinkus, Ph.D., Review Officer, Office of Extramural Affairs, HUMAN SERVICES
Scientific Review Officer, Center for National Institute on Drug Abuse, NIH,
Scientific Review, National Institutes of DHHS, Room 4227, MSC 9550, 6001 National Institutes of Health
Health, 6701 Rockledge Drive, Room 4132, Executive Boulevard, Bethesda, MD 20892–
MSC 7802, Bethesda, MD 20892, (301) 435– 9550, (301) 827–5702 lf33c.nih.gov. Center for Scientific Review; Notice of
1214, pinkusl@csr.nih.gov. Closed Meetings
(Catalogue of Federal Domestic Assistance
Name of Committee: Center for Scientific Program No.: 93.279, Drug Abuse and
Review Special Emphasis Panel; Pursuant to section 10(d) of the
Addiction Research Programs, National
Fellowships: Endocrinology, Metabolism, Federal Advisory Committee Act, as
Institutes of Health, HHS)
Nutrition, and Reproductive Science. amended (5 U.S.C. App.), notice is
Date: July 31, 2017. Dated: June 26, 2017. hereby given of the following meetings.
Time: 12:00 p.m. to 5:00 p.m. Natasha M. Copeland, The meetings will be closed to the
Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory public in accordance with the
applications. Committee Policy. provisions set forth in sections
Place: National Institutes of Health, 6701 [FR Doc. 2017–13697 Filed 6–29–17; 8:45 am] 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Rockledge Drive, Bethesda, MD 20892, as amended. The grant applications and
BILLING CODE 4140–01–P
(Virtual Meeting).
the discussions could disclose
Contact Person: Elaine Sierra-Rivera, Ph.D.,
Scientific Review Officer, EMNR IRG, Center confidential trade secrets or commercial
for Scientific Review, National Institutes of DEPARTMENT OF HEALTH AND property such as patentable material,
Health, 6701 Rockledge Drive, Room 6182 HUMAN SERVICES and personal information concerning
MSC 7892, Bethesda, MD 20892, 301 435– individuals associated with the grant
2514, riverase@csr.nih.gov. National Institutes of Health applications, the disclosure of which
(Catalogue of Federal Domestic Assistance would constitute a clearly unwarranted
Program Nos. 93.306, Comparative Medicine; National Human Genome Research invasion of personal privacy.
93.333, Clinical Research, 93.306, 93.333, Institute; Notice of Closed Meeting
Name of Committee: Center for Scientific
93.337, 93.393–93.396, 93.837–93.844,
Pursuant to section 10(d) of the Review Special Emphasis Panel; Cellular
93.846–93.878, 93.892, 93.893, National Aspects of Metabolism.
Institutes of Health, HHS) Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is Date: July 11, 2017.
Dated: June 26, 2017. Time: 1:00 p.m. to 3:00 p.m.
hereby given of the following meeting. Agenda: To review and evaluate grant
Sylvia L. Neal, The meeting will be closed to the applications.
Program Analyst, Office of Federal Advisory public in accordance with the Place: National Institutes of Health, 6701
Committee Policy. provisions set forth in sections Rockledge Drive, Bethesda, MD 20892
[FR Doc. 2017–13692 Filed 6–29–17; 8:45 am] 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., (Telephone Conference Call).
BILLING CODE 4140–01–P as amended. The grant applications and Contact Person: Antonello Pileggi, Ph.D.,
the discussions could disclose MD., Scientific Review Officer, Center for
Scientific Review, National Institutes of
confidential trade secrets or commercial Health, 6701 Rockledge Drive, Room 6166,
DEPARTMENT OF HEALTH AND property such as patentable material,
HUMAN SERVICES Bethesda, MD 20892–7892, (301) 402–6297,
and personal information concerning pileggia@csr.nih.gov.
National Institutes of Health individuals associated with the grant This notice is being published less than 15
applications, the disclosure of which days prior to the meeting due to the timing
National Institute on Drug Abuse; would constitute a clearly unwarranted limitations imposed by the review and
Notice of Closed Meeting invasion of personal privacy. funding cycle.
Name of Committee: Center for Inherited Name of Committee: Center for Scientific
Pursuant to section 10(d) of the Disease Research Access Committee, CIDR Review Special Emphasis Panel;
Federal Advisory Committee Act, as Neurogenesis and Cell Fate MAKE-UP.
Member Conflict,
amended (5 U.S.C. App), notice is Date: July 11–12, 2017.
Date: July 21, 2017.
Time: 1:00 p.m. to 2:00 p.m.
hereby given of the following meeting. Time: 12:30 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
The meeting will be closed to the Agenda: To review and evaluate grant
applications.
public in accordance with the applications. Place: National Institutes of Health, 6701
provisions set forth in sections Place: National Institutes of Health, 5635 Rockledge Drive, Bethesda, MD 20892
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Fishers Lane, Suite 3051, Bethesda, MD (Virtual Meeting).
20892 (Telephone Conference Call). Contact Person: Joanne T Fujii, Ph.D.,
as amended. The contract proposals and Contact Person: Rudy Pozzatti, Ph.D.,
the discussions could disclose Scientific Review Officer, Center for
mstockstill on DSK30JT082PROD with NOTICES

Scientific Review Officer, Scientific Review Scientific Review, National Institutes of
confidential trade secrets or commercial Branch, National Human Genome Research Health, 6701 Rockledge Drive, Room 4184,
property such as patentable material, Institute, 5635 Fishers Lane, Suite 4076, MSC MSC 7850, Bethesda, MD 20892 (301) 435–
and personal information concerning 9306, Bethesda, MD 20852, (301) 402–0838, 1178, fujiij@csr.nih.gov.
individuals associated with the contract pozzattr@mail.nih.gov.
This notice is being published less than 15
proposals, the disclosure of which (Catalogue of Federal Domestic Assistance days prior to the meeting due to the timing
would constitute a clearly unwarranted Program Nos. 93.172, Human Genome limitations imposed by the review and
invasion of personal privacy. Research, National Institutes of Health, HHS) funding cycle.

VerDate Sep<11>2014 17:32 Jun 29, 2017 Jkt 241001 PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 E:\FR\FM\30JNN1.SGM 30JNN1

Document Created: 2017-06-30 06:02:16
Document Modified: 2017-06-30 06:02:16

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 27, 2017.
FR Citation		82 FR 29908

82 FR 29908 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 125 (June 30, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health